News
12h
The Holy Mess on MSNGLP-1 Weight Loss Drugs: Miracle, Mess, or Something in Between?Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...
FROM sulphur burps to diarrhoea and nausea, there are many widely known Ozempic side effects – but there’s also a whole host of nasty long-term issues experts are only just uncovering.
5h
Interesting Engineering on MSNDr. Ilana Ressler on how fertility and metabolism are connectedListen to Dr. Ilana Ressler explain PCOS and its significance in fertility and metabolic health on our latest episode.
5h
Live Science on MSNCan weight loss drugs help you drink less alcohol?There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...
4."Any kind of silly diet. Paleo, Keto, Carnivore, etc. Health science doesn’t change. Only the fads. Stick to a balanced ...
Swiss pharma giant Novartis is diving into research on ageing to tap the growing market for drugs that help keep older adults ...
Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital will participate ...
GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...
Glucagon-like peptide 1 receptor agonist treatment is not associated with an increased risk for psychiatric adverse events or worsening depressive symptoms.
In patients with T2D, GLP-1s don’t increase the risk for acute pancreatitis, mitigate the risk for complications in those who ...
GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results